These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22383964)

  • 1. TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules.
    Zhang L; Chen Y; Wong HS; Zhou S; Mamitsuka H; Zhu S
    PLoS One; 2012; 7(2):e30483. PubMed ID: 22383964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
    Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
    Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan.
    Nielsen M; Lundegaard C; Blicher T; Peters B; Sette A; Justesen S; Buus S; Lund O
    PLoS Comput Biol; 2008 Jul; 4(7):e1000107. PubMed ID: 18604266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An effective and effecient peptide binding prediction approach for a broad set of HLA-DR molecules based on ordered weighted averaging of binding pocket profiles.
    Shen WJ; Zhang S; Wong HS
    Proteome Sci; 2013 Nov; 11(Suppl 1):S15. PubMed ID: 24565049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.
    Nielsen M; Lundegaard C; Lund O
    BMC Bioinformatics; 2007 Jul; 8():238. PubMed ID: 17608956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.
    Bordner AJ; Mittelmann HD
    BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes.
    Jørgensen KW; Buus S; Nielsen M
    PLoS One; 2010 Dec; 5(12):e15877. PubMed ID: 21209859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research.
    Lin HH; Zhang GL; Tongchusak S; Reinherz EL; Brusic V
    BMC Bioinformatics; 2008 Dec; 9 Suppl 12(Suppl 12):S22. PubMed ID: 19091022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Class II MHC-Peptide binding: a kernel based approach using similarity scores.
    Salomon J; Flower DR
    BMC Bioinformatics; 2006 Nov; 7():501. PubMed ID: 17105666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices.
    Sturniolo T; Bono E; Ding J; Raddrizzani L; Tuereci O; Sahin U; Braxenthaler M; Gallazzi F; Protti MP; Sinigaglia F; Hammer J
    Nat Biotechnol; 1999 Jun; 17(6):555-61. PubMed ID: 10385319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC2SKpan: a novel kernel based approach for pan-specific MHC class II peptide binding prediction.
    Guo L; Luo C; Zhu S
    BMC Genomics; 2013; 14 Suppl 5(Suppl 5):S11. PubMed ID: 24564280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of an epitope prediction tool for swine (PigMatrix) based on the pocket profile method.
    Gutiérrez AH; Martin WD; Bailey-Kellogg C; Terry F; Moise L; De Groot AS
    BMC Bioinformatics; 2015 Sep; 16():290. PubMed ID: 26370412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Peptide Binding Prediction Approach for HLA-DR Molecule Based on Sequence and Structural Information.
    Li Z; Zhao Y; Pan G; Tang J; Guo F
    Biomed Res Int; 2016; 2016():3832176. PubMed ID: 27340658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide binding predictions for HLA DR, DP and DQ molecules.
    Wang P; Sidney J; Kim Y; Sette A; Lund O; Nielsen M; Peters B
    BMC Bioinformatics; 2010 Nov; 11():568. PubMed ID: 21092157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC2MIL: a novel multiple instance learning based method for MHC-II peptide binding prediction by considering peptide flanking region and residue positions.
    Xu Y; Luo C; Qian M; Huang X; Zhu S
    BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S9. PubMed ID: 25521198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class II epitope predictive algorithms.
    Nielsen M; Lund O; Buus S; Lundegaard C
    Immunology; 2010 Jul; 130(3):319-28. PubMed ID: 20408898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3.
    Consogno G; Manici S; Facchinetti V; Bachi A; Hammer J; Conti-Fine BM; Rugarli C; Traversari C; Protti MP
    Blood; 2003 Feb; 101(3):1038-44. PubMed ID: 12393675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA.
    Jucaud V
    J Immunol Res; 2017; 2017():2748614. PubMed ID: 28331856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity.
    Oyarzún P; Ellis JJ; Bodén M; Kobe B
    BMC Bioinformatics; 2013 Feb; 14():52. PubMed ID: 23409948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.